Abstract
ObjectiveClinical trialists, meta-analysts and clinical guideline developers are increasingly using minimal important differences (MIDs) to enhance the interpretability of patient-reported outcome measures (PROMs). Here, we elucidate three critical issues of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have